Nalaganje...

Predictive role of skin rash in advanced pancreatic cancer patients treated with gemcitabine plus erlotinib: a systematic review and meta-analysis

PURPOSE: The survival benefit from gemcitabine plus erlotinib was on average marginal for advanced pancreatic cancer (APC) patients. Skin rash developed shortly after starting treatment seemed to be associated with better efficacy and might be used to assist clinical decision-making, but the results...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Onco Targets Ther
Main Authors: Zeng, Minyan, Feng, Qi, Lu, Ming, Zhou, Jun, Yang, Zuyao, Tang, Jinling
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2018
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6188168/
https://ncbi.nlm.nih.gov/pubmed/30349297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S168418
Oznake: Označite
Brez oznak, prvi označite!